Merck's SWOT analysis: stock outlook amid oncology competition, pipeline growth
Co., Inc. (NYSE:MRK), a global healthcare leader, faces a complex landscape of opportunities and challenges as it navigates the competitive biopharmaceutical industry. This comprehensive analysis ...
MM&M2d
Merck promotes Johanna Herrmann to SVP, global communications
Herrmann will continue in her role as chief of staff to EVP and chief communications and public affairs officer Cristal Downing.
Jefferies Reaffirms Their Buy Rating on Merck & Company (MRK)
In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...
Hosted on MSN9d
Merck Falls 9% in 3 Months: Buy, Hold or Sell the Stock?
Key Takeaways Merck faces headwinds like declining sales of the HPV vaccine, Gardasil, and diabetes drug, Januvia. Merck ...
Yahoo Finance1mon
How Much Would It Take To Earn $100 A Month From Merck Stock
Merck & Co. (NYSE:MRK) is a global health care company that delivers innovative health solutions through its prescription medicines, vaccines, biologic therapies and animal health products.
Hosted on MSN15d
What to Expect From Merck & Co.'s Q4 2024 Earnings Report
With a market cap of $252.6 billion, Rahway, New Jersey-based Merck & Co., Inc. (MRK) is a global leader in the healthcare ...